Research output per year
Research output per year
Personal profile
Research interests
Dr. Gao’s primary research interests focus on the joint modeling of longitudinal and survival data, especially the effects of longitudinal biomarker fluctuation on clinical outcomes. He collaborates with clinicians in various clinical trials and translational studies to bring basic scientific findings into diagnostic and therapeutic endpoints. He provides statistical expertise in modeling health-related quality of life data, assessing circadian rhythms and sleep/wake disturbance for cancer survivors, and monitoring disease progression in patients with early phase glaucoma. Dr. Gao is a faculty biostatistician in Biostatistics and Qualitative Research Shared Resource at Siteman Cancer Center (SCC). He provides statistical support as a lead faculty biostatistician in SCC Hematopoietic Development and Malignancy Program (HDMP). His responsibilities include study design, safety monitoring, data analysis, and manuscript/abstract preparation.
Fingerprint
Dive into the research topics where Feng Gao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Improving cancer prevention and control through implementing academic-local public health department partnerships – protocol for a cluster-randomized implementation trial using a positive deviance approach
Mazzucca-Ragan, S., Allen, P., Amos, K., Barker, A. R., Brewer, M., Erwin, P. C., Gannon, J., Gao, F., Jacob, R. R., Lengnick-Hall, R. & Brownson, R. C., Dec 2025, In: Implementation Science Communications. 6, 1, 20.Research output: Contribution to journal › Article › peer-review
Open Access -
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Abboud, R., Schroeder, M. A., Rettig, M. P., Jayasinghe, R. G., Gao, F., Eisele, J., Gehrs, L., Ritchey, J., Choi, J., Abboud, C. N., Pusic, I., Jacoby, M., Westervelt, P., Christopher, M., Cashen, A., Ghobadi, A., Stockerl-Goldstein, K., Uy, G. L. & DiPersio, J. F., Mar 27 2025, In: Blood. 145, 13, p. 1382-1394 13 p.Research output: Contribution to journal › Article › peer-review
-
Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response: EARLY PHASE STUDIES
Jacoby, M. A., Duncavage, E. D., Khanna, A., Chang, G. S., Nonavinkere Srivatsan, S., Miller, C. A., Gao, F., Robinson, J., Shao, J., Fulton, R. S., Fronick, C. C., O’Laughlin, M., Heath, S. E., Brendel, K., Chavez, M., DiPersio, J. F., Abboud, C. N., Stockerl-Goldstein, K., Westervelt, P. & Cashen, A. & 7 others, , Jan 2025, In: Leukemia. 39, 1, p. 166-177 12 p.Research output: Contribution to journal › Article › peer-review
-
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer
Auberle, C., Gao, F., Sloan, M., Morgensztern, D., Winkler, L., Ward, J. P., Devarakonda, S., Rearden, T. P., Govindan, R. & Waqar, S. N., Jun 30 2024, In: Journal of Thoracic Disease. 16, 6, p. 3782-3793 12 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetes
Grandhi, N., Liu, L., Wang, M., Thomas, T., Schoen, M., Sanfilippo, K., Gao, F., Colditz, G. A., Carson, K. R., Janakiram, M. & Chang, S. H., Dec 1 2024, In: JNCI Cancer Spectrum. 8, 6, pkae095.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations